Xencor | XNCR - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
AbbVie USD 41.64B 458M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amgen USD 25.5B 547M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Biogen USD 3.92B 918.2M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Cytokinetics USD 181.43M 17.76M 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
J&J USD 54.9B 2.82B 2026-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
MacroGenics USD 95.94M 52.82M 2026-03
Merck USD 27.73B 786M 2026-06
Novartis USD 31.75B 374M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Xencor USD 81.86M 8.41M 2026-06